Japanese approval for Positron's PET (positron emission tomography) scanners:
This article was originally published in Clinica
Executive Summary
Houston, Texas-based Positron has received Japanese approval to market its line of Posicam-HZ positron emission tomography scanners. The systems are designed for use in cardiology, neurology and oncology applications. Imatron-Japan, the exclusive Japanese distributor of the scanners, predicts that of more than 500 systems will be installed in Japan within the next five years.
You may also be interested in...
Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion
Two Chairs, which uses algorithms to match the right therapists with patients, secured $72m in investment to expand its business.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.